Novel in vitro diagnosis or prognosis of malignant melanoma
A Spanish university together with a genomics research institute have identified a new group of single nucleotide polymorphisms related to the risk and aggressiveness of malignant melanoma. An in vitro method was developed for the diagnosis or prognosis of malignant melanoma and to determine whether these patients respond adequately to a treatment. The entities are looking for companies working in the field of oncology interested in licensing this patented technology.